JNJ vs ZBH
By Alex · Tickerpine
Johnson & Johnson vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ZBH |
|---|---|---|
| Price | $260.86 | $97.89 |
| Market cap | $628.65B | $18.67B |
| P/E ratio | 30.3 | 23.6 |
| ROE | 25.74% | 6.41% |
| Profit margin | 21.48% | 9.48% |
| Revenue growth | 6.60% | 4.80% |
| Dividend yield | 2.05% | 0.98% |
| Beta | 0.23 | 0.46 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ZBH in plain English
- JNJ is the bigger company — about 33.7× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 23.6 vs 30.3).
- JNJ earns a higher return on equity (26% vs 6%).
- JNJ is growing revenue faster (7% vs 5%).
- JNJ has the higher dividend yield (2.05% vs 0.98%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.